The iQMedix team offers medical-molecular analysis in the human field, especially for cancer patients. We have relocated from Hamburg to Mannheim in the Rhine-Neckar region, which is known worldwide for its large-scale research facilities in the field of life sciences and oncology in particular.
Our analyses and the validation of the assays and reagents are carried out in accordance with the guidelines of the German Medical Association (Rili-BÄK) and the internationally binding MIQE standards, the devices involved in the molecular biological analysis are CE-certified.
iQMedix is part of a network that includes oncologists, surgeons, radiologists, pathologists, specialized specialists and specialist clinics to enable direct implementation of the results.
The iQMedix team consists of colleagues from various disciplines, such as molecular biology, medicine, biotechnology and engineering.
Our team
The developer of Metavectum diagnostics is Dr. rer. nat. Bert Steffan, who has already successfully analyzed over 3000 patients. He is co-founder of iQMedix, Managing Director and Scientific Director.
Dr. Reinhard Becker is a multiple successful entrepreneur, co-founder of iQMedix, Managing Director and responsible for technological issues.
Dr.-Ing. Bernd Becker is a multiple successful entrepreneur, co-founder of iQMedix, Managing Director and responsible for marketing.
The core team in the scientific and laboratory work consists of Dr. Tim Förster, microbiologist and Head of Operations,
M.Sc. Julian Pfohl, microbiologist,
Dr. Anja Pelizaeus, microbiologist,
M.Sc. Constanze Nagl, Medical Biology
M.Sc. Marie-Claire Henka, Engineering is Product Manager.
You can reach us via the contact page here!